Drug Fix: A New Director For US FDA’s Biologics Center, Guidance Production Slowdowns
Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider early excitement and concern about Vi...
Scrip's Five Must-Know Things - 7 May 2025
Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 May 2025. In this episode: AstraZeneca CEO cautions Eur...
Everything You Wanted To Know About Real World Evidence, With IQVIA’s Volker Spitzer
The potential for real world evidence (RWE) is huge, according to enthusiasts, but to the uninitiated it can seem like a complicated and forbidding su...
OPPI’s Matai On India’s IPR Regime: Progress, Pain Points, Possibilities
Anil Matai, director general, Organization of Pharmaceutical Producers of India, discusses the evolving intellectual property landscape in India post ...
Drug Fix: Vaccine Review Political Interference, Missed Deadlines A Harbinger Of US FDA Problems?
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor in Chief Nielsen Hobbs consider the...
Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?
Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Ala...
Conference Catch-Up: BIO-Europe 2025
In this episode, we recap the key takeaways from BIO-Europe 2025, held in Milan, Italy, in March 2025, with Trajko Spasenovski, Vice President of Stra...
Highlights from AAN 2025
Emma Wille and Summer Colling discuss the 2025 American Academy of Neurology (AAN) conference with CNS and I&I analysts Wen-Yu Huang, Joseph Jacob and...
Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs
Aragen Life Sciences’s CEO Manni Kantipudi - also former CIO of Intel Asia - speaks with Citeline’s senior editor Vibha Ravi about the changing global...
Scrip's Five Must-Know Things - 28 April 2025
Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 April 2025. In this episode: 2024’s top-selling drugs;...